Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Advancements in Immunotherapy: Harnessing Cellular Immunity for Clinical Benefit
Short Communication: Int J Inflam Cancer Integr Ther 2024, 11: 270
Cellular Immunology in Infectious Diseases: From Host Defense to Pathogenesis
Short Communication: Int J Inflam Cancer Integr Ther 2024, 11: 271
Engineering Immune Cells for Precision Immunotherapy: Promises and Pitfalls
Review Article: Int J Inflam Cancer Integr Ther 2024, 11: 272
Review Article: Int J Inflam Cancer Integr Ther 2024, 11: 273
Immune Dysregulation in Chronic Inflammatory Diseases: Insights into Pathogenesis and Therapy
Mini Review: Int J Inflam Cancer Integr Ther 2024, 11: 274
Innate Immune Memory: Unraveling Mechanisms and Implications for Vaccination Strategies
Opinion: Int J Inflam Cancer Integr Ther 2024, 11: 275
Targeting Immune Checkpoints in Cancer Immunotherapy: Current Trends and Future Directions
Short Communication: Int J Inflam Cancer Integr Ther 2024, 11: 276
The Immunomodulatory Role of Regulatory T Cells: Therapeutic Opportunities and Challenges
Opinion: Int J Inflam Cancer Integr Ther 2024, 11: 277
The Interplay between Gut Microbiota and Immune System: Implications for Health and Disease
Perspective: Int J Inflam Cancer Integr Ther 2024, 11: 278
Understanding the Role of T-Cell Subsets in Autoimmune Disorders: Implications for Therapy
Perspective: Int J Inflam Cancer Integr Ther 2024, 11: 279
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals